XM does not provide services to residents of the United States of America.

Morgan Stanley latest to downgrade ASML on China, memory, Intel concerns



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Morgan Stanley latest to downgrade ASML on China, memory, Intel concerns</title></head><body>

AMSTERDAM, Sept 20 (Reuters) -Morgan Stanley on Friday downgraded earnings estimates for computer chip equipment maker ASML ASML.AS, the latest brokerage to do so following weakness in the memory chip market and concerns over demand from Chinese chipmakers and Intel INTC.O.

MS followed UBS and Deutsche Bank in cutting estimates and reducing share price targets for ASML after the company's share price slid 30% in July and August.

"Investors may have to wrestle with weakness not just with DRAM (memory chip market) but also with Intel ... and the growing concern that China semiconductor capacity overspend will slow as we look to 2026," MS analysts wrote.

ASML's shares were down 2.7% at 727.80 euros at 1209 GMT on Friday.

Intel last week paused its plans to expand in Germany for two years as it cuts capital spending amid a major rehaul of its bespoke chip-making arm.

MS hedged its advice, noting that ASML will still see a strong 2025 with AI-linked demand for its most advanced EUV tools from top chip manufacturer TSMC 2330.TW.

"History warns against being too negative on ASML before an order book cycle has hit peak," it said.

Deutsche Bank analysts also questioned prospects for ASML's China business, which made up nearly half of ASML's sales in the second quarter despite being for its less-advanced DUV product line.

"We now understand that the outlook for lagging spend in China has deteriorated, with over-capacity appearing," analysts wrote.

Chinese memory chip makers such as CMXT may be added to the U.S. Entity List, which restricts trade with certain companies and would limit ASML's ability to sell to them, Deutsche Bank said.

In a contrary view, Citi on Wednesday said ASML is their top tech pick in Europe following the summer sell-off.

Analysts said they expect a healthy order influx when the company reports earnings on Oct. 16.



Reporting by Toby Sterling; Editing by Susan Fenton

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.